The global biotechnology contract manufacturing market is experiencing remarkable growth, with a steady increase in revenue over the years. According to the latest research, the market was estimated to be worth a substantial $16.6 billion in 2023 and is poised to reach an impressive $24.8 billion by 2028. This growth is driven by a robust compound annual growth rate (CAGR) of 8.3% projected...